Nov 13, 2008 - AMAG Pharmaceuticals, Inc. today announced that the U.S. FDA has designated the Company's resubmission to the October 2008 Complete Response letter for its NDA for ferumoxytol as a complete, Class 1 response.
The details can be read here.
No comments:
Post a Comment